Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
21 févr. 2024 08h15 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...